Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2001 | 02-2001 | 11-2000 | 08-2000 | 05-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,170 | 46,100 | 33,020 | 16,500 | 3,090 |
| Depreciation Amortization | 6,100 | 22,960 | 16,860 | 11,200 | 5,560 |
| Other Working Capital | -1,630 | 9,970 | -13,400 | -16,740 | 16,150 |
| Other Operating Activity | 310 | -1,020 | 2,480 | 520 | 280 |
| Operating Cash Flow | $7,950 | $78,010 | $38,960 | $11,480 | $25,080 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,470 | -41,710 | -19,690 | -9,100 | -5,040 |
| Net Acquisitions | -53,430 | 0 | 0 | 0 | N/A |
| Other Investing Activity | 0 | -200 | 28,580 | 28,640 | -60 |
| Investing Cash Flow | $-70,900 | $-41,910 | $8,890 | $19,540 | $-5,100 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 36,630 | -26,570 | -27,780 | -28,420 | -27,540 |
| Financing Cash Flow | $36,630 | $-26,570 | $-27,780 | $-28,420 | $-27,540 |
| Beginning Cash Position | 36,670 | 27,140 | 27,140 | 27,140 | 27,140 |
| End Cash Position | 10,340 | 36,670 | 47,220 | 29,750 | 19,580 |
| Net Cash Flow | $-26,320 | $9,530 | $20,080 | $2,600 | $-7,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,950 | 78,010 | 38,960 | 11,480 | 25,080 |
| Free Cash Flow | 7,950 | 78,010 | 38,960 | 11,480 | 25,080 |